Avantor, Inc. (NYSE:AVTR – Get Free Report) has been assigned an average recommendation of “Reduce” from the seventeen ratings firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $10.4688.
AVTR has been the subject of a number of analyst reports. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. Wolfe Research cut shares of Avantor to an “underperform” rating and set a $7.00 price objective for the company. in a report on Monday, June 1st. Barclays lifted their price objective on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday. Royal Bank Of Canada initiated coverage on shares of Avantor in a report on Thursday, May 14th. They set a “sector perform” rating and a $9.00 price objective for the company. Finally, Sanford C. Bernstein initiated coverage on shares of Avantor in a report on Friday. They set a “market perform” rating and a $10.50 price objective for the company.
Get Our Latest Research Report on Avantor
Insider Activity
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its holdings in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Private Trust Co. NA boosted its holdings in Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor during the second quarter worth about $32,000. Los Angeles Capital Management LLC purchased a new position in Avantor during the fourth quarter worth about $32,000. Finally, Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Avantor Stock Up 0.1%
Shares of NYSE AVTR opened at $10.30 on Monday. The stock has a market capitalization of $7.03 billion, a P/E ratio of -12.71, a P/E/G ratio of 5.96 and a beta of 0.97. The company has a 50-day moving average price of $8.70 and a 200-day moving average price of $9.49. Avantor has a 1 year low of $7.26 and a 1 year high of $15.93. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The business’s revenue was up .0% on a year-over-year basis. During the same period last year, the company earned $0.23 earnings per share. On average, equities research analysts forecast that Avantor will post 0.79 EPS for the current fiscal year.
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Further Reading
- Five stocks we like better than Avantor
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
